Plain-English translation of NCT07463989 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are creating the first comprehensive map of skin lymphomas in Italy by collecting medical information from about 1,000 patients. This observational study looks at past and new patient cases to understand how common these rare skin cancers are, what types occur most often, and whether where you live or environmental exposures might affect your risk.
Italy currently has no centralized registry tracking skin lymphomas, making it difficult for doctors to understand how many people are affected, identify patterns, or spot geographic clusters of the disease. This study aims to fill that gap and help researchers discover potential links between the environment and skin lymphoma development.
You likely qualify if…
You likely don't qualify if…
If you participate, researchers will review your medical records from your dermatology (skin specialist) care, including your diagnosis details, treatment history, lab results, and diagnostic tests—all information that's already part of your standard care. The study includes both patients diagnosed between 2018 and 2022 (retrospective review) and newly diagnosed patients who will be followed for three years. Your participation involves sharing this existing medical information; no new procedures or treatments are required.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Italy
Enrollment target
~1,000 participants
Started
May 2025
Primary completion
May 2028
Age range
2 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alessandro Pileri, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.